Search Here

A pharmaceuticals startup is creating prefabricated drug dosages that could be used by compounding pharmacists to support patient-centered medicines, according to reports. 

Teresa Carvajal, chief operating officer at Biokorf LLC and a faculty member in Purdue's Department of Agricultural and Biological Engineering, said in a press release that compounding pharmacists fill prescriptions for individual patients, whereas the pharmaceutical industry makes a reproducible product in very large quantities for the general patient population.

"The one-size-fits-all approach used in industrial pharmacy does not work for individual prescriptions," she said. "Prescription drugs require dosing flexibility with a very high level of precision in order for them to work as intended for the specific patient."

Rodolfo Pinal, chief scientific officer at Biokorf and associate professor in Purdue's Department of Industrial and Physical Pharmacy, added the company has developed technology that provides the necessary level of precision. It could strengthen a compounding pharmacist's ability to provide a patient-centered approach to medicine.

"We have created 3D Integrated Pharmaceuticals, which provides prefabricated components that compounding pharmacists assemble according to pre-established blueprints," he said. "These components include the drug dosage as well as performance traits such as solubilization control and taste masking."

The report added that the 3D integrated Pharmaceuticals technology has been exclusively licensed to Biokorf through the Purdue Office of Technology Commercialization.